HSBC Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $309K | Buy |
+1,014
| New | +$309K | ﹤0.01% | 1960 |
|
2025
Q1 | – | Sell |
-2,091
| Closed | -$643K | – | 2666 |
|
2024
Q4 | $643K | Buy |
2,091
+515
| +33% | +$158K | ﹤0.01% | 1649 |
|
2024
Q3 | $338K | Buy |
1,576
+6
| +0.4% | +$1.29K | ﹤0.01% | 1892 |
|
2024
Q2 | $440K | Sell |
1,570
-20,787
| -93% | -$5.83M | ﹤0.01% | 1703 |
|
2024
Q1 | $5.95M | Buy |
22,357
+5,408
| +32% | +$1.44M | ﹤0.01% | 878 |
|
2023
Q4 | $3.92M | Buy |
16,949
+2,706
| +19% | +$626K | ﹤0.01% | 989 |
|
2023
Q3 | $2.08M | Hold |
14,243
| – | – | ﹤0.01% | 1104 |
|
2023
Q2 | $3.29M | Buy |
14,243
+3,353
| +31% | +$775K | ﹤0.01% | 1004 |
|
2023
Q1 | $2.64M | Buy |
+10,890
| New | +$2.64M | ﹤0.01% | 1129 |
|